nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromfenac—PTGS1—malignant glioma	0.616	0.636	CbGaD
Bromfenac—PTGS2—malignant glioma	0.352	0.364	CbGaD
Bromfenac—Tolmetin—CXCL8—malignant glioma	0.000887	0.0838	CrCbGaD
Bromfenac—Balsalazide—PPARG—malignant glioma	0.000848	0.0801	CrCbGaD
Bromfenac—PTGS2—S1P1 pathway—SPHK1—malignant glioma	0.000783	0.0375	CbGpPWpGaD
Bromfenac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—malignant glioma	0.000742	0.0355	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—YEATS4—malignant glioma	0.000658	0.0315	CbGpPWpGaD
Bromfenac—Balsalazide—PTGS1—malignant glioma	0.000626	0.0591	CrCbGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—PTGS1—malignant glioma	0.000581	0.0278	CbGpPWpGaD
Bromfenac—Lumiracoxib—PTGS1—malignant glioma	0.000573	0.0541	CrCbGaD
Bromfenac—Nepafenac—PTGS1—malignant glioma	0.000545	0.0514	CrCbGaD
Bromfenac—Indomethacin—CXCL8—malignant glioma	0.000541	0.0511	CrCbGaD
Bromfenac—Fenbufen—PTGS1—malignant glioma	0.000521	0.0492	CrCbGaD
Bromfenac—Diclofenac—CYP2C18—malignant glioma	0.00051	0.0482	CrCbGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—PTK2—malignant glioma	0.000509	0.0244	CbGpPWpGaD
Bromfenac—Diclofenac—CXCL8—malignant glioma	0.000488	0.0461	CrCbGaD
Bromfenac—PTGS2—Eicosanoid Synthesis—PTGS1—malignant glioma	0.000482	0.0231	CbGpPWpGaD
Bromfenac—Tolmetin—PTGS1—malignant glioma	0.000453	0.0428	CrCbGaD
Bromfenac—PTGS2—Spinal Cord Injury—ROS1—malignant glioma	0.000447	0.0214	CbGpPWpGaD
Bromfenac—Suprofen—PTGS1—malignant glioma	0.000434	0.041	CrCbGaD
Bromfenac—Ketoprofen—CXCL8—malignant glioma	0.000433	0.0409	CrCbGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—PTK2—malignant glioma	0.000404	0.0194	CbGpPWpGaD
Bromfenac—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—malignant glioma	0.000403	0.0193	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—FN1—malignant glioma	0.000386	0.0185	CbGpPWpGaD
Bromfenac—Diclofenac—CYP2B6—malignant glioma	0.000379	0.0358	CrCbGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000378	0.0181	CbGpPWpGaD
Bromfenac—Indomethacin—PPARG—malignant glioma	0.000374	0.0353	CrCbGaD
Bromfenac—PTGS1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00036	0.0172	CbGpPWpGaD
Bromfenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—malignant glioma	0.000358	0.0172	CbGpPWpGaD
Bromfenac—Balsalazide—PTGS2—malignant glioma	0.000358	0.0338	CrCbGaD
Bromfenac—PTGS2—S1P1 pathway—PDGFB—malignant glioma	0.00034	0.0163	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—PIM1—malignant glioma	0.000337	0.0161	CbGpPWpGaD
Bromfenac—Lumiracoxib—PTGS2—malignant glioma	0.000327	0.0309	CrCbGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—PIK3CD—malignant glioma	0.000325	0.0156	CbGpPWpGaD
Bromfenac—PTGS2—S1P1 pathway—KDR—malignant glioma	0.000318	0.0153	CbGpPWpGaD
Bromfenac—PTGS1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000312	0.0149	CbGpPWpGaD
Bromfenac—Nepafenac—PTGS2—malignant glioma	0.000311	0.0294	CrCbGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—FN1—malignant glioma	0.000306	0.0147	CbGpPWpGaD
Bromfenac—Fenbufen—PTGS2—malignant glioma	0.000298	0.0281	CrCbGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—BCL2—malignant glioma	0.000295	0.0141	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—PTGS2—malignant glioma	0.00028	0.0134	CbGpPWpGaD
Bromfenac—Indomethacin—PTGS1—malignant glioma	0.000276	0.0261	CrCbGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—CXCL8—malignant glioma	0.000272	0.013	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—BCAN—malignant glioma	0.000271	0.013	CbGpPWpGaD
Bromfenac—PTGS2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000268	0.0128	CbGpPWpGaD
Bromfenac—Tolmetin—PTGS2—malignant glioma	0.000259	0.0244	CrCbGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—PIK3CD—malignant glioma	0.000258	0.0124	CbGpPWpGaD
Bromfenac—Diclofenac—PTGS1—malignant glioma	0.000249	0.0235	CrCbGaD
Bromfenac—Suprofen—PTGS2—malignant glioma	0.000248	0.0234	CrCbGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—BCL2—malignant glioma	0.000234	0.0112	CbGpPWpGaD
Bromfenac—PTGS1—Eicosanoid Synthesis—PTGS2—malignant glioma	0.000233	0.0111	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—MYB—malignant glioma	0.000225	0.0108	CbGpPWpGaD
Bromfenac—Ketoprofen—PTGS1—malignant glioma	0.000221	0.0209	CrCbGaD
Bromfenac—PTGS2—Spinal Cord Injury—GDNF—malignant glioma	0.000218	0.0105	CbGpPWpGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—CXCL8—malignant glioma	0.000216	0.0103	CbGpPWpGaD
Bromfenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—malignant glioma	0.000201	0.00964	CbGpPWpGaD
Bromfenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—malignant glioma	0.000195	0.00932	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—CYP2B6—malignant glioma	0.000191	0.00916	CbGpPWpGaD
Bromfenac—PTGS1—Overview of nanoparticle effects—TNF—malignant glioma	0.000189	0.00907	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—GFAP—malignant glioma	0.000188	0.00899	CbGpPWpGaD
Bromfenac—PTGS2—S1P1 pathway—VEGFA—malignant glioma	0.000175	0.0084	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—PTGS1—malignant glioma	0.00017	0.00817	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—CYP2C18—malignant glioma	0.000166	0.00794	CbGpPWpGaD
Bromfenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malignant glioma	0.000166	0.00793	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—LGALS3—malignant glioma	0.000164	0.00786	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—SOD1—malignant glioma	0.000163	0.0078	CbGpPWpGaD
Bromfenac—Indomethacin—PTGS2—malignant glioma	0.000158	0.0149	CrCbGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000157	0.0075	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—CAT—malignant glioma	0.000155	0.0074	CbGpPWpGaD
Bromfenac—PTGS2—Overview of nanoparticle effects—TNF—malignant glioma	0.00015	0.0072	CbGpPWpGaD
Bromfenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malignant glioma	0.000147	0.00705	CbGpPWpGaD
Bromfenac—Diclofenac—PTGS2—malignant glioma	0.000142	0.0135	CrCbGaD
Bromfenac—PTGS1—Biological oxidations—GSTT1—malignant glioma	0.000134	0.00642	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—malignant glioma	0.000131	0.00625	CbGpPWpGaD
Bromfenac—PTGS1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000129	0.0062	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—SOD1—malignant glioma	0.000129	0.00619	CbGpPWpGaD
Bromfenac—Ketoprofen—PTGS2—malignant glioma	0.000126	0.0119	CrCbGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—CAT—malignant glioma	0.000123	0.00588	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—HES1—malignant glioma	0.000121	0.00579	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—NCOR1—malignant glioma	0.00012	0.00576	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000119	0.00568	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000113	0.00544	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—F2—malignant glioma	0.000113	0.00543	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000112	0.00539	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malignant glioma	0.000107	0.00513	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—GJA1—malignant glioma	0.000106	0.00506	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.0001	0.0048	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—malignant glioma	9.96e-05	0.00477	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—malignant glioma	9.53e-05	0.00457	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malignant glioma	9.52e-05	0.00456	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—RTEL1—malignant glioma	9.39e-05	0.0045	CbGpPWpGaD
Bromfenac—PTGS1—Biological oxidations—GSTP1—malignant glioma	9.29e-05	0.00445	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	9.17e-05	0.00439	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—F2—malignant glioma	8.99e-05	0.00431	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	8.65e-05	0.00414	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—IFNG—malignant glioma	8.58e-05	0.00411	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—PTGS2—malignant glioma	8.23e-05	0.00394	CbGpPWpGaD
Bromfenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—malignant glioma	8.13e-05	0.00389	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	7.95e-05	0.00381	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	7.78e-05	0.00373	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—IL1B—malignant glioma	7.66e-05	0.00367	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—RTEL1—malignant glioma	7.46e-05	0.00357	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	7.41e-05	0.00355	CbGpPWpGaD
Bromfenac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	7.35e-05	0.00352	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—CDKN2A—malignant glioma	7.25e-05	0.00347	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—BCL2—malignant glioma	7.14e-05	0.00342	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	7.13e-05	0.00342	CbGpPWpGaD
Bromfenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malignant glioma	6.93e-05	0.00332	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—IFNG—malignant glioma	6.81e-05	0.00326	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.71e-05	0.00322	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	6.63e-05	0.00318	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	6.57e-05	0.00315	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.5e-05	0.00311	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—IL1B—malignant glioma	6.08e-05	0.00291	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	5.97e-05	0.00286	CbGpPWpGaD
Bromfenac—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	5.55e-05	0.00266	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—COX8A—malignant glioma	5.4e-05	0.00259	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	5.39e-05	0.00258	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	5.33e-05	0.00256	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.33e-05	0.00255	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.16e-05	0.00247	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	5.01e-05	0.0024	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	4.91e-05	0.00235	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	4.81e-05	0.0023	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	4.79e-05	0.0023	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—IL2—malignant glioma	4.79e-05	0.00229	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	4.78e-05	0.00229	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	4.63e-05	0.00222	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—ASMT—malignant glioma	4.59e-05	0.0022	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	4.57e-05	0.00219	CbGpPWpGaD
Bromfenac—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	4.54e-05	0.00218	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	4.53e-05	0.00217	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.48e-05	0.00215	CbGpPWpGaD
Bromfenac—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	4.41e-05	0.00211	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—BCAN—malignant glioma	4.31e-05	0.00207	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—COX8A—malignant glioma	4.28e-05	0.00205	CbGpPWpGaD
Bromfenac—PTGS2—Disease—BCAN—malignant glioma	4.09e-05	0.00196	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	3.9e-05	0.00187	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.83e-05	0.00183	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—MYC—malignant glioma	3.74e-05	0.00179	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	3.7e-05	0.00177	CbGpPWpGaD
Bromfenac—PTGS2—Disease—DTX1—malignant glioma	3.7e-05	0.00177	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	3.66e-05	0.00175	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	3.65e-05	0.00175	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—ASMT—malignant glioma	3.64e-05	0.00174	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	3.63e-05	0.00174	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	3.59e-05	0.00172	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.56e-05	0.00171	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TNF—malignant glioma	3.49e-05	0.00167	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—IDH2—malignant glioma	3.48e-05	0.00167	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—BCAN—malignant glioma	3.42e-05	0.00164	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.28e-05	0.00157	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CYP2B6—malignant glioma	3.27e-05	0.00157	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	3.26e-05	0.00156	CbGpPWpGaD
Bromfenac—PTGS2—Spinal Cord Injury—TP53—malignant glioma	3.07e-05	0.00147	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.06e-05	0.00147	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—IDH1—malignant glioma	2.99e-05	0.00143	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HEY2—malignant glioma	2.9e-05	0.00139	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—SPHK1—malignant glioma	2.89e-05	0.00139	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CYP2C18—malignant glioma	2.83e-05	0.00136	CbGpPWpGaD
Bromfenac—PTGS2—Disease—IDH1—malignant glioma	2.83e-05	0.00136	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.77e-05	0.00133	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—IDH2—malignant glioma	2.76e-05	0.00132	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HEY1—malignant glioma	2.69e-05	0.00129	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.67e-05	0.00128	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HIST1H3B—malignant glioma	2.61e-05	0.00125	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.6e-05	0.00125	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CYP2B6—malignant glioma	2.6e-05	0.00124	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.55e-05	0.00122	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.49e-05	0.00119	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.43e-05	0.00117	CbGpPWpGaD
Bromfenac—PTGS2—Disease—JAG2—malignant glioma	2.38e-05	0.00114	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—IDH1—malignant glioma	2.37e-05	0.00114	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.37e-05	0.00114	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.35e-05	0.00113	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.35e-05	0.00113	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—SPHK1—malignant glioma	2.3e-05	0.0011	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTT1—malignant glioma	2.29e-05	0.0011	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CYP2C18—malignant glioma	2.25e-05	0.00108	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.16e-05	0.00104	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.14e-05	0.00103	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.12e-05	0.00102	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.09e-05	0.001	CbGpPWpGaD
Bromfenac—PTGS2—Disease—H3F3A—malignant glioma	2.02e-05	0.000966	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—BCHE—malignant glioma	2e-05	0.000957	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—SLC5A5—malignant glioma	1.97e-05	0.000945	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.93e-05	0.000926	CbGpPWpGaD
Bromfenac—PTGS2—Disease—JAG1—malignant glioma	1.9e-05	0.000911	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.87e-05	0.000894	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.87e-05	0.000894	CbGpPWpGaD
Bromfenac—PTGS2—Disease—FBXW7—malignant glioma	1.86e-05	0.000892	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.85e-05	0.000886	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTT1—malignant glioma	1.82e-05	0.000872	CbGpPWpGaD
Bromfenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.77e-05	0.000846	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PTGS1—malignant glioma	1.71e-05	0.000817	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.7e-05	0.000814	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.61e-05	0.000772	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—GSTP1—malignant glioma	1.59e-05	0.000761	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—BCHE—malignant glioma	1.59e-05	0.00076	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—SLC5A5—malignant glioma	1.57e-05	0.00075	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CAT—malignant glioma	1.55e-05	0.000741	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.48e-05	0.00071	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—NCOR1—malignant glioma	1.46e-05	0.0007	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CDKN2B—malignant glioma	1.46e-05	0.000699	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HES1—malignant glioma	1.39e-05	0.000667	CbGpPWpGaD
Bromfenac—PTGS2—Disease—NCOR1—malignant glioma	1.38e-05	0.000663	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PDGFRA—malignant glioma	1.33e-05	0.000635	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.28e-05	0.000613	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—GSTP1—malignant glioma	1.26e-05	0.000604	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CAT—malignant glioma	1.23e-05	0.000588	CbGpPWpGaD
Bromfenac—PTGS2—Disease—TERT—malignant glioma	1.22e-05	0.000584	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HLA-A—malignant glioma	1.22e-05	0.000584	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PDGFB—malignant glioma	1.19e-05	0.00057	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—CAV1—malignant glioma	1.19e-05	0.00057	CbGpPWpGaD
Bromfenac—PTGS2—Disease—FGFR1—malignant glioma	1.18e-05	0.000567	CbGpPWpGaD
Bromfenac—PTGS2—Disease—HIF1A—malignant glioma	1.17e-05	0.000559	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—NCOR1—malignant glioma	1.16e-05	0.000555	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.14e-05	0.000545	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CAV1—malignant glioma	1.13e-05	0.000541	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PIK3CG—malignant glioma	1.08e-05	0.000519	CbGpPWpGaD
Bromfenac—PTGS2—Disease—BAD—malignant glioma	1.06e-05	0.000508	CbGpPWpGaD
Bromfenac—PTGS2—Disease—NOTCH1—malignant glioma	1.05e-05	0.000504	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PPARG—malignant glioma	1.05e-05	0.000501	CbGpPWpGaD
Bromfenac—PTGS2—Disease—CD80—malignant glioma	1.03e-05	0.000493	CbGpPWpGaD
Bromfenac—PTGS2—Disease—APC—malignant glioma	1.03e-05	0.000492	CbGpPWpGaD
Bromfenac—PTGS2—Disease—EGF—malignant glioma	1.02e-05	0.000487	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PTPN11—malignant glioma	1.01e-05	0.000484	CbGpPWpGaD
Bromfenac—PTGS2—Disease—BRAF—malignant glioma	9.66e-06	0.000463	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PIK3CD—malignant glioma	9.53e-06	0.000457	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—CAV1—malignant glioma	9.45e-06	0.000453	CbGpPWpGaD
Bromfenac—PTGS2—Disease—AKT2—malignant glioma	9.4e-06	0.000451	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PIK3CD—malignant glioma	9.03e-06	0.000433	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.03e-06	0.000433	CbGpPWpGaD
Bromfenac—PTGS2—Disease—FGF2—malignant glioma	8.65e-06	0.000414	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PIK3CG—malignant glioma	8.61e-06	0.000412	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PIK3CB—malignant glioma	8.31e-06	0.000398	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PPARG—malignant glioma	8.31e-06	0.000398	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PTGS2—malignant glioma	8.23e-06	0.000394	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MDM2—malignant glioma	8.09e-06	0.000388	CbGpPWpGaD
Bromfenac—PTGS2—Disease—RAF1—malignant glioma	8.07e-06	0.000386	CbGpPWpGaD
Bromfenac—PTGS2—Disease—ERBB2—malignant glioma	7.98e-06	0.000382	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PIK3CB—malignant glioma	7.88e-06	0.000377	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PIK3CD—malignant glioma	7.57e-06	0.000363	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PTEN—malignant glioma	7.18e-06	0.000344	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PTEN—malignant glioma	6.8e-06	0.000326	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PIK3CB—malignant glioma	6.6e-06	0.000316	CbGpPWpGaD
Bromfenac—PTGS2—Disease—STAT3—malignant glioma	6.09e-06	0.000292	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PTEN—malignant glioma	5.7e-06	0.000273	CbGpPWpGaD
Bromfenac—PTGS2—Disease—MYC—malignant glioma	5.66e-06	0.000271	CbGpPWpGaD
Bromfenac—PTGS2—Disease—EGFR—malignant glioma	5.53e-06	0.000265	CbGpPWpGaD
Bromfenac—PTGS2—Disease—KRAS—malignant glioma	5.23e-06	0.00025	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—PIK3CA—malignant glioma	5.06e-06	0.000243	CbGpPWpGaD
Bromfenac—PTGS2—Disease—PIK3CA—malignant glioma	4.8e-06	0.00023	CbGpPWpGaD
Bromfenac—PTGS1—Metabolism—AKT1—malignant glioma	4.14e-06	0.000198	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—PIK3CA—malignant glioma	4.02e-06	0.000193	CbGpPWpGaD
Bromfenac—PTGS2—Disease—AKT1—malignant glioma	3.92e-06	0.000188	CbGpPWpGaD
Bromfenac—PTGS2—Metabolism—AKT1—malignant glioma	3.28e-06	0.000157	CbGpPWpGaD
